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Although it is established that defective clear-
ance and, hence, increased accumulation of
apoptotic cells can lead to autoimmunity, the
mechanism by which this occurs remains elu-
sive. Here, we observed that apoptotic cells
undergoing secondary necrosis but not intact
apoptotic cells provoked substantial immune
responses, which were mediated through the
toll-like receptor 2 (TLR2) pathway. The devel-
opment of autoimmune diabetes was markedly
inhibited in Tlr2/ mice but not in Tlr4/
mice, showing that TLR2 plays an important
role in the initiation of the disease. Apoptotic
b-cell injury could stimulate the priming of
diabetogenic T cells through a TLR2-depen-
dent, but TLR4-independent, activation of anti-
gen-presenting cells. These findings suggest
that b-cell death and its sensing via TLR2 may
be an initial event for the stimulation of anti-
gen-presenting cells and development of auto-
immune diabetes.
INTRODUCTION
Apoptosis is a process of removing harmful or useless
cells and is fundamental to the maintenance of mamma-
lian homeostasis. Apoptotic cells are rapidly engulfed by
phagocytes such as macrophages, and thereby the re-
lease of potentially cytotoxic or inflammatory cellular
contents is prevented (Savill et al., 2002). Phagocytosis
of apoptotic cells can also provide immunosuppressive
effects (Savill et al., 2002). However, the simple dichot-
omy of apoptotic cells resulting in immunosuppression
and necrotic cells provoking immunity (Gallucci et al.,
1999) is now being questioned. There is increasing
body of evidence that apoptotic cells can, under certain
circumstances, induce immune responses and inflamma-tion (Rovere et al., 1998; Mevorach et al., 1998). Indeed,
an increased formation or a defective clearance of apo-
ptotic cells have been closely linked to autoimmune and
inflammatory disorders (Botto et al., 1998; Hanayama
et al., 2004).
Type 1 diabetes (T1D) is an autoimmune disorder result-
ing from the specific destruction of pancreatic b-cells pro-
ducing insulin. Despite extensive studies regarding the
progression and final effector mechanism of T1D (Eizirik
and Mandrup-Poulsen, 2001; Suk et al., 2001), relatively
little information exists concerning the initial steps in the
development of T1D. However, a recent study has pro-
posed that a wave of physiological b-cell apoptosis, peak-
ing at 14–17 days after birth, might be an initial stimulus
for triggering anti-islet immune responses (Turley et al.,
2003). In pancreatic lymph nodes (PLNs), b-cell-specific
T cells are primed by dendritic cells (DCs) that ferry the
debris from apoptotic b-cells, and then activated T cells
invade islets thereafter. This event may be pronounced
in nonobese diabetic (NOD) mice, an animal model of
T1D, which might reflect the reported defect in the phago-
cytosis of apoptotic cells by macrophages in those mice
(O’Brien et al., 2006).
These studies suggest that apoptotic cells should be
cleared at an early stage so that they could be prevented
from undergoing secondary necrosis that would deliver
endogenous stimuli that could activate the immune
system. However, it is not understood how the accumu-
lation of apoptotic cells can prime such autoimmune re-
sponses and which receptor(s) and signaling pathway(s)
mediate those responses. In this study, we investigated
the mechanisms by which the interaction between
phagocytes and apoptotic islet cells triggers immune re-
sponses and the development of autoimmune diabetes.
We found that apoptotic b-cells undergoing secondary
necrosis could stimulate the priming of diabetogenic
T cells through a toll-like receptor 2 (TLR2)-dependent
activation of antigen-presenting cells (APCs). The rele-
vance of this finding was further supported by marked
inhibition of the development of autoimmune diabetes in
Tlr2/ mice.Immunity 27, 321–333, August 2007 ª2007 Elsevier Inc. 321
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TLR2-Dependent Initiation of Autoimmune DiabetesFigure 1. SN Cells Induce Substantial
Proinflammatory Responses
(A) For inducing apoptosis, MIN6N8 cells were
irradiated 20mJ/cm2 and left for 6 hr (intact ap-
optotic, apop) or for 30 hr (secondary necrotic,
SN). Primary necrotic (PN) cells were prepared
by dounce lysis. Cells were then subjected to
FACS analysis after annexin V-FITC and PI
staining (top). Changes in cellular size and
granularity were assessed by FSC and SSC
(bottom).
(B) Peritoneal macrophages were left un-
treated () or incubated with MIN6N8 cells (vi-
able, apoptotic, SN, or PN) for 6 hr with or with-
out IFN-g. Cytokine release was determined by
ELISA. NO accumulation was measured by the
Griess method. As a control, 10 ng/ml LPS was
included.
(C) Macrophages were incubated with apopto-
tic or SN MIN6N8, NIT-1, NIE115, and NIH 3T3
cells for 6 hr. TNF-a release was measured by
ELISA.
(D and E) Macrophages were left untreated ()
or incubated with apoptotic, SN, and PN pri-
maryMEF (D) or apoptotic, SN, and PN primary
islet (E) for 6 hr. TNF-a release was measured
by ELISA. The differences between apoptotic
and SN groups were statistically significant
for all comparisons ([B]–[E]; *p < 0.05). The
data (means ± SE) in (B)–(E) represent results
from three independent experiments per-
formed in triplicate.RESULTS
Macrophage Responses to Apoptotic or
Necrotic Cells
In young NOD mice, accumulation of apoptotic b-cells
was observed during a physiological wave of b-cell apo-
ptosis (Trudeau et al., 2000), which has been closely linked
to the initiation of anti-islet autoimmunity (Turley et al.,
2003). Accumulated apoptotic cells can often undergo
a late phase of apoptosis, also known as secondary ne-
crosis, when left for a long time because of inefficient re-
moval (Rovere et al., 1998; Ip and Lau, 2004). Because
macrophages are the first immune cells to invade pancre-
atic islets preceding T cell infiltration in NODmice and their
depletion results in a complete prevention of insulitis and
diabetes (Jun et al., 1999), we first studied the responses
of macrophages to apoptotic islet cells. To determine the
ability of apoptotic cells to induce inflammatory responses
depending on their apoptotic states, we prepared apopto-
tic MIN6N8 insulinoma cells with intact membrane integ-
rity or those undergoing secondary necrosis by UV irradi-
ation (Figure 1A). Greater than 50% of intact apoptotic
cells were annexin V+, and less than 5% of them were322 Immunity 27, 321–333, August 2007 ª2007 Elsevier Inc.PI+. Greater than 70% of secondary necrotic (SN) cells
were annexin V+, and greater than 50% of them were
PI+. Primary necrotic (PN) cells were prepared by dounce
lysis as described (Li et al., 2001), resulting in lysis of
greater than 90% of the cells. In addition to PI uptake,
PN cells showed predominant binding of annexin V prob-
ably because of abundant distribution of phosphatidylser-
ine in the cellular membranes (Vance, 1991). Cell death
was also characterized by morphological changes of the
injured cells. As cell death proceeds, apoptotic cells
showed a progressive decrease in forward light scatter
(FSC) and an increase in side light scatter (SSC) compared
to viable cells. Then, we measured the cytokines TNF-a,
IL-12 p70, and IL-1b and nitric oxide (NO), which are
important players in T1D (Mathis et al., 2001; Eizirik and
Mandrup-Poulsen, 2001). Interestingly, SN cells induced
substantial production of those cytokines from macro-
phages of C57BL/6 mice as did PN cells (Figure 1B). We
could not detect TNF-a, NO, IL-12 p70, or IL-1b in the
supernatant of MIN6N8 cells (viable, apoptotic, SN, and
PN) or resting peritoneal macrophages regardless of the
presence of IFN-g (data not shown), ruling out possible re-
lease of those cytokines from deadMIN6N8 cells. Further,
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TLR2-Dependent Initiation of Autoimmune Diabetesthe viability of macrophages was not changed upon addi-
tion of SN or PN cells throughout the incubation, eliminat-
ing possible contribution of macrophage death to the pro-
duction of cytokines (data not shown). Of note is the
finding that, unlike lipopolysaccharide (LPS), SN cells did
not elicit detectable NO or IL-12 p70 production in the ab-
sence of IFN-g, a cytokine produced by activated T cells
(Figure 1B), suggesting that SN cells and LPS use different
signaling pathways.
AlthoughMIN6N8 cells are relevant to our study, it is not
known whether other cell types induce similar macro-
phage responses. We therefore employed apoptotic
N1E115 neuroblastoma, NIH 3T3 fibroblast, and NIT-1,
another insulinoma cell. Again, these SN cells induced
substantial TNF-a production (Figure 1C). Next, we inves-
tigated whether SN primary cells also induce similar TNF-
a production from macrophages in the same manner as
SN transformed cells. SN primary murine embryonic fibro-
blasts (MEFs) derived from two different mouse strains in-
duced substantial TNF-a production (Figure 1D and data
not shown). Although the amount produced was lower
than that by SN transformed cells or SN primary MEFs,
SN primary islet cells also induced significant TNF-a pro-
duction from macrophages (Figure 1E; p < 0.05). PN cells
from primary MEFs or islet cells consistently induced sig-
nificant TNF-a production from macrophages (Figures 1D
and 1E). Of interest is the finding that, despite similar na-
ture of SN or PN cells inducing TNF-a production from
macrophages, there exist significant differences in the
amount of TNF-a production by SN or PN cells depending
on the cell types, with the most potent TNF-a production
by transformed cells. The relatively greater amount of
TNF-a production by transformed cells or primary MEFs
compared to primary islet cells might be in part due to
high expression of stress-related molecules such as
heat-shock proteins (HSPs) in these cells (Welch, 1993;
Jolly and Morimoto, 2000). Taken together, these results
suggest that, similar to PN cells, apoptotic cells escaping
phagocytic clearance and undergoing secondary necrosis
can provoke cytokine responses from macrophages.
NF-kB Activation by SN Cells
We next studied the role of NF-kB activation in SN cell-in-
duced inflammatory cytokine production from macro-
phages because a recent paper showed NF-kB activation
by PN cells (Li et al., 2001). EMSA indicated that nuclear
translocation of NF-kB occurred in macrophages after
incubation with SN or PN MIN6N8 cells but not after incu-
bation with intact apoptotic cells (Figure 2A). We also de-
tected the degradation of cytoplasmic IkBa upon incuba-
tion with SN MIN6N8 cells (Figure S1 in the Supplemental
Data available online). To directly correlate the NF-kB
activation and inflammatory cytokine production, we in-
fected macrophages with adenovirus-expressing IkBa-
superrepressor (Ad5IkBa-SR) that is resistant to protea-
somal degradation and that inhibits NF-kB activation
(Chang et al., 2003). The production of inflammatory cyto-
kines after exposure to SN MIN6N8 cells was abrogated
by Ad5IkBa-SR but not by a control Ad5LacZ (Figure 2B).Next, we investigated whether SN primary cells also
induce TNF-a production from macrophages through
NF-kB activation. Reporter assay indicated that SN
primary MEFs induced significantly increased NF-kB acti-
vation compared to intact apoptotic primary MEFs
(Figure 2C; p < 0.05). Inhibition of NF-kB activation by
Ad5IkBa-SR also abrogated TNF-a production in
response to SN primary MEFs (Figure 2D) or SN primary
islet cells (Figure 2E; p < 0.05), suggesting that TNF-a
production by SN-cell-mediated NF-kB activation is not
restricted to transformed cells.
Receptor(s) for SN Cells
Major pathways for receptor-mediated NF-kB activation
in inflammatory responses include TNF and IL-1-TLR sig-
naling. Because of no detection of TNF-a or IL-1b in the
supernatant of MIN6N8 cells (viable, apoptotic, SN, and
Figure 2. Proinflammatory Responses by SN Cells Are
Mediated by NF-kB Activation
(A) Macrophages were left untreated () or treated with MIN6N8 cells
(apoptotic, SN, and PN) for 1 hr. NF-kB DNA binding activity was
determined by EMSA. As a control, 10 ng/ml LPS and TNF-a were
included. The specificity of binding was evaluated by competition
with added wild-type kB oligonucleotide (cold).
(B) Macrophages were left untreated (control) or infected with adeno-
virus (multiplicity of infection of 50) harboring IkBa-SR or LacZ for 24 hr
and then treated with SN MIN6N8 cells for 6 hr with or without IFN-g.
The production of TNF-a, NO, and IL-12 p70 in the supernatant was
determined.
(C) RAW 264.7 cells were transfected in duplicate with pELAM-luc and
pRL-TK plasmids for 24 hr. Transfected cells were left untreated () or
treated with apoptotic, SN MEF, PGN, or LPS for 6 hr. Relative firefly
luciferase activities of NF-kB reporter normalized to Renilla luciferase
activities are shown (*p < 0.05).
(D and E) Macrophages were left untreated (control) or infected with
IkBa-SR or LacZ adenovirus for 24 hr and then incubated with SN
primary MEF (D) or SN primary islet cells (E) for 6 hr. TNF-a release
was measured by ELISA (*p < 0.05). The data (means ± SE) in (B)–(E)
represent results from three independent experiments performed in
triplicate.Immunity 27, 321–333, August 2007 ª2007 Elsevier Inc. 323
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TLR2-Dependent Initiation of Autoimmune DiabetesFigure 3. TLR2, but Not TLR4, Mediates Proinflammatory Responses to SN Cells
(A) RAW 264.7 cells were transfected in duplicate with MyD88(DN) or empty pcDNA vector together with pELAM-luc and pRL-TK plasmids for 24 hr.
Transfected cells were left untreated () or treated with MIN6N8 cells (apoptotic and SN), PGN, and LPS for 6 hr. Relative firefly luciferase activities of
NF-kB reporter normalized to Renilla luciferase activities are shown.
(B) Macrophages fromMyd88/ and their respective control mice were left untreated () or incubated with MIN6N8 cells (apoptotic, SN, and PN) or
apoptotic, SN, and PN primaryMEF for 6 hr. TNF-a releasewasmeasured by ELISA. The data (means ± SE) shown in (A) and (B) represent results from
three independent experiments.
(C) Macrophages were left untreated (w/o SN, left) or incubated with PI-stained SN cells for 30 min (w SN, right), and were sequentially treated with
anti-TLR2 or -TLR4 primary Ab, biotinylated secondary Ab, and streptavidin-FITC conjugate. Shown are the representative results of confocalmicros-
copy.
(D and E)Macrophageswere left untreated () or treatedwith SNMIN6N8 cells, PGN, or LPS for the indicated times. As shown in (D), RT-PCR analysis
was performed for detecting the expression of TNF-a, IL-1b and IFN-b in macrophages. b-actin was included as a control. As shown in (E), phosphor-
ylation of STAT1 on tyrosine 701(Y701P) or serine 727 (S727P) and total STAT1 level were determined by immunoblotting. The data shown in (C)–(E)
are representative of three independent experiments.
(F) HEK293 cells were transfected with murine TLR2, TLR4, or empty vector together with pELAM-luc, pRL-TK, and, where indicated, CD14-MD2
plasmids for 24 hr. Transfected cells were left untreated () or treated with apoptotic, SN, PN MIN6N8, PGN, or LPS for 6 hr, and relative luciferase
activities were measured.
(G and H) Macrophages from Tlr2/, Tlr4/, and their respective control mice were incubated with various SN MIN6N8 cells (UV irradiation, STZ,
etoposide, IFN-g plus TNF-a) or PNMIN6N8 cells for 6 hr. TNF-a releasewasmeasured by ELISA. As controls, 100 ng/ml PGN and 10 ng/ml LPSwere
included.324 Immunity 27, 321–333, August 2007 ª2007 Elsevier Inc.
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TLR2-Dependent Initiation of Autoimmune DiabetesPN) or resting peritoneal macrophages, we focused our in-
vestigation on TLR signaling. We first tested the effect of
blocking MyD88, a common adaptor protein in the TLR
pathway, on the macrophage responses to SN cells. In-
triguingly, the expression of a MyD88 dominant negative
(DN) construct in RAW264.7 cells markedly inhibited NF-
kB activation by SN cells (Figure 3A). Next, we prepared
macrophages from Myd88/ mice (Adachi et al., 1998)
and analyzed the TNF-a production in response to SN or
PN cells. TNF-a production by SN or PN cells was dimin-
ished in macrophages from Myd88/ mice (Figure 3B),
suggesting a key role of MyD88 in macrophage responses
to SN or PN cells.
Putative endogenous ligands that trigger TLR signaling
may be composed of proteinaceous material acting
through TLR2 or TLR4 (Beg, 2002), chromatin-Ab com-
plexes through TLR9 (Leadbetter et al., 2002), dsRNA or
ssRNA through TLR3 (Alexopoulou et al., 2001), TLR7, or
TLR8 (Heil et al., 2004). Treatment of supernatant from
SN or PN cells with proteinase K-agarose, but not with
DNase or RNase, abrogated TNF-a producing activity,
suggesting dominant proteinaceous nature of the endog-
enous stimuli from both SN and PN cells (Figure S2). Thus,
we chose TLR2 and TLR4 as potential candidates. Confo-
cal microscopy revealed that both TLR2 and TLR4 were
expressed and mainly localized on the surface of macro-
phages (Figure 3C). Interestingly, upon incubation with
SN cells, both TLR2 and TLR4 were recruited to phago-
somes containing SN cells (Figure 3C), indicating that
TLRs are recruited to phagosomes and recognize endog-
enous stimuli.
Although TLR stimulation leads to a common activation
of MAPKs and NF-kB, functional responses induced by
distinct TLR agonists can be distinguished by the inflam-
matory genes induced and by STAT1 signaling (Toshcha-
kov et al., 2002). As shown in Figure 3D, SN cells rapidly
induced the expression of TNF-a and IL-1b mRNA, as
did LPS (TLR4 agonist) or peptidoglycan (PGN) (TLR2 ag-
onist). However, LPS, but not PGN or SN cells, induced
a rapid induction of IFN-b mRNA (Figure 3D). Incubation
with SN cells, like PGN, also induced selective phosphor-
ylation of serine 727 but not that of tyrosine 701 of STAT1
(Figure 3E). Because it is well known that phosphorylation
of STAT1 tyrosine 701 is mediated by LPS-induced IFN-
b (Toshchakov et al., 2002), these data suggest the prefer-
ential involvement of TLR2, rather than TLR4.
To prove the specific involvement of TLR2 in SN-cell-
mediated NF-kB activation, we transiently expressed
TLR2, TLR4, and CD14-MD2, along with a kB reporter
construct in HEK293 cells. The expression of TLR2, but
not TLR4, resulted in the dramatic NF-kB activation by
SN or PN cells, whereas intact apoptotic cells did not ac-
tivate NF-kB in HEK293 cells transfected with TLR2 or
TLR4 (Figure 3F). Next, we prepared SN and PN cells byusingvariousagents andanalyzed the responsesofmacro-
phages from Tlr2/ and Tlr4/ (C3H/HeJ) mice. TNF-a
production was markedly attenuated in macrophages
from Tlr2/ but not in those from Tlr4/mice, suggesting
that TLR2-NF-kB activation is critical for such responses
(Figures 3G and 3H). Interestingly, TNF-a production in
response to PN cells, in contrast to that to SN cells, was
slightly decreased inmacrophages from Tlr4/mice com-
pared to control Tlr4+/+ (C3H/HeN) mice, suggesting that
PN cells, unlike SN cells, may release intracellular noxious
contents with additional specificities toward TLR4 as well
as TLR2 (Figure 3H). Thiswas further supportedby the find-
ing that PN cells, but not SN cells, slightly induced the
expression of IFN-bmRNA and phosphorylation of STAT1
tyrosine 701; such expression and phosphorylation were
both partially dependent on TLR4 (Figure S3). SN cells
may have a limited repertoire of endogenous stimuli be-
cause of the regulated removal of intracellular contents in
contrast to PN cells. When primary MEFs or primary islet
cells were employed instead of MIN6N8 cells, we again
observed that TNF-a production by Tlr2/ macrophages
in response to SN primary cells was significantly lower
than that by Tlr2+/+ macrophages (Figures 3I and 3J; p <
0.05). Although PN cells from primary MEFs and islet cells
induced significant TNF-a production through a TLR2-
dependent pathway, they elicited residual TNF-a release
from Tlr2/ macrophages (Figures 3I and 3J); this
response might be due to partial TLR4-dependent signal-
ing, similar to the macrophage responses to PN MIN6N8
cells (Figure S3).
TLR2 and Development of Autoimmune Diabetes
To validate the relevance of our finding that SN cells could
induce proinflammatory response through TLR2-depen-
dent pathway in vitro, we next explored whether an in-
creased cell death and accumulation of dead cells could
promote autoimmune diabetes through a TLR2-depen-
dent mechanism in vivo. For this purpose, we employed
two types of autoimmune diabetes models—multiple
low-dose streptozotocin (STZ) model and NOD mouse
model.Whenadministered inmultiple low-dose,STZ, ase-
lective cytotoxic agent against pancreatic b-cells, induces
accumulation of apoptotic b-cells and development of au-
toimmune diabetes in susceptible strains (Elias et al.,
1994).We found that Tlr2/mice of C57BL/6 background
were significantly resistant to the STZ-induced auto-
immune diabetes compared to Tlr2+/+ mice (Figure 4A;
p = 0.023). In contrast, Tlr4/mice showed no significant
difference in the incidence of diabetes compared to their
control Tlr4+/+ mice (Figure 4B; p > 0.1). Histological anal-
ysis revealed substantial mononuclear inflammatory cells
surrounding and infiltrating pancreatic islets in STZ-
treated diabetic Tlr2+/+ mice but not in most Tlr2/ mice
(data not shown). However, in Tlr2/mice that developed(I and J) Macrophages from Tlr2+/+ and Tlr2/mice were left untreated () or incubated with apoptotic, SN, and PN primary MEF (I) or apoptotic, SN,
and PN primary islet cells (J) for 6 hr. TNF-a release was measured by ELISA (*p < 0.05 compared to SN islet-treated macrophages from Tlr2/mice
or apoptotic islet-treated macrophages from Tlr2+/+ mice).
The data (means ± SE) shown in (F)–(J) represent results from three independent experiments.Immunity 27, 321–333, August 2007 ª2007 Elsevier Inc. 325
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TLR2-Dependent Initiation of Autoimmune DiabetesFigure 4. Tlr2/ Mice Are Resistant to the Development of Autoimmune Diabetes
(A) Tlr2+/+ (n = 13) and Tlr2/ (n = 14) male mice of C57BL/6 background were treated with 30 mg/kg STZ for 5 consecutive days.
(B) Tlr4+/+ (n = 7) and Tlr4/ (n = 13) male mice were treated with multiple low-dose STZ as described in (A).
(C) Cumulative incidence of spontaneous diabetes in littermate female NOD.Tlr2+/+ (n = 34), NOD.Tlr2+/ (n = 38), and NOD.Tlr2/ (n = 24) mice.
(D) Representative pancreatic sections from 14- to 16-week-old littermate female NOD.Tlr2+/+ and NOD.Tlr2/ mice stained with hematoxylin and
eosin are shown.
(E) The extent of insulitis was assessed as described (Suk et al., 2001) (nine mice for NOD.Tlr2+/+ and six mice for NOD.Tlr2/; 30–50 islets
per mouse).diabetes, insulitis was detected in some islets (data not
shown). To further support the TLR2-dependent develop-
ment of autoimmune diabetes, we performed the same
experiment by using Myd88/ mice of C57BL/6 back-
ground. Myd88/ mice were also significantly resistant
to the STZ-induced autoimmune diabetes compared to
Myd88+/+ mice (Figure S4; p = 0.021), suggesting that the
adaptor molecule MyD88 mediates the resistance of
Tlr2/mice to the STZ-induced autoimmune diabetes.
Next, we employed NOD mouse model, a more physio-
logical animal model for human T1D. In NOD mice, b-cell
apoptosis has been implicated not only in the last step
of T1D (Suk et al., 2001) but also in the initiation phase
of the disease as an important trigger for the priming of di-
abetogenic T cells (Trudeau et al., 2000). Therefore, to in-
vestigate the importance of TLR2 in autoimmune diabetes
of NOD mice, we backcrossed Tlr2/ mice on C57BL/6
background to NOD mice for nine generations before in-
tercrossing them to obtain NOD.Tlr2+/+ and NOD.Tlr2/
mice. In this process, pups homozygous for NOD MHC
alleles (H-2g7/g7; Idd1) and also for other diabetes suscep-
tibility Idd loci (Idd2 Idd15) were selected at the fifth
backcross and were used for further backcrossing. Com-
parison of the incidence of spontaneous T1D indicated
that TLR2 deficiency confers a significant protection
against the development of T1D. Kaplan-Meier curve
analysis showed that although 74% of NOD.Tlr2+/+ mice326 Immunity 27, 321–333, August 2007 ª2007 Elsevier Inc.became diabetic until 45 weeks of age, 38% of littermate
NOD.Tlr2/ mice developed diabetes during the same
observation period (Figure 4C; p = 0.0029), suggesting
a significant contribution of TLR2 to the development of
spontaneous T1D. Histological analysis revealed that
both diabetic and nondiabetic NOD.Tlr2+/+ mice had se-
vere destructive insulitis in pancreatic islets, but most
islets of NOD.Tlr2/mice hadmoderate peri-insulitis (Fig-
ures 4Dand4E). The average insulitis score inNOD.Tlr2/
mice was 0.42 ± 0.167 (mean ± SE, n = 6) at 14–16 weeks
and was significantly lower than that of NOD.Tlr2+/+ mice
(1.64 ± 0.327; n = 9) (p < 0.05). Destructive insulitis was de-
tected in diabetic NOD.Tlr2/ mice as well as mice with
STZ-induced autoimmune diabetes (data not shown). In
contrast, the incidence of diabetes and the severity of
insulitis were not decreased in NOD.Tlr4/ mice (unpub-
lished data). Taken together, our results suggest that
TLR2 signaling contributes to the development of autoim-
munediabetes in T1Dmodels causedbyb-cell injury and in
a spontaneous T1D model of NOD mice.
DC Activation and Diabetogenic CD4+ T Cell
Priming In Vitro
To dissect the mechanism underlying the protection of
T1D in Tlr2/ mice, we first investigated whether TLR2
is important for the initiation of T1D by mediating APC
activation and by subsequent priming of diabetogenic
Immunity
TLR2-Dependent Initiation of Autoimmune DiabetesFigure 5. SN b-Cells Induce the Prolifer-
ation of Diabetogenic T Cells through
TLR2-Dependent Activation of DCs
In Vitro
(A) TLR2-dependent maturation of BMDCs by
SN cells. Tlr2+/+ or Tlr2/ BMDCs were cocul-
tured with SN MIN6N8 cells for 18 hr and
examined for the expression of the indicated
surface markers by FACS gated on CD11c+
cells. Numbers indicate the mean fluorescent
intensities (outlined trace, media alone; filled
trace, SN cell-treated; D, increase of the fluo-
rescence intensity after stimulation).
(B) NOD.Tlr2+/+ or NOD.Tlr2/ BMDCs were
prepared and pulsed with intact apoptotic or
SN MIN6N8 cells for 16 hr. Graded numbers
of pulsed DCs were then incubated with
CFSE-labeled naive BDC2.5 CD4+ T cells
(4 3 105) for 3 days. Proliferation of BDC2.5
CD4+ T cells by pulsed BMDCs was measured
by CFSE dilution in CD4+Vb4+ cells.
(C) BMDCs were prepared and pulsed as de-
scribed in (B) and then incubated with naive
BDC2.5 CD4+ T cells (2.5:1 DC to T ratio). After
3 days of culture, the supernatant was tested
for IFN-g release.
(D) CD11c+ DCs were purified from the spleens
of NOD.Tlr2+/+ or NOD.Tlr2/mice and pulsed
with apoptotic or SNprimary islet cells for 20 hr.
Graded numbers of pulsed DCs were incu-
bated with naive BDC2.5 CD4+ T cells (1 3
105). After 3 days of culture, proliferation of
BDC2.5 CD4+ T cells was determined by mea-
suring the incorporation of [3H]-thymidine for
the next 16 hr (*p < 0.05 compared to SN islet-
pulsed DCs from NOD.Tlr2/mice or apopto-
tic islet-pulsed DCs from NOD.Tlr2+/+ mice).
(E) Splenic DCs were purified and pulsed as
described in (D) and incubated with naive
BDC2.5 CD4+ T cells (1:1 DC to T ratio). After
4 days of culture, the supernatant was tested
for IFN-g release (*p < 0.05). The data (means ±
SE) shown in (B)–(E) represent results from three
independent experiments done in triplicate.T cells. Because TLR signaling is important for the devel-
opment of adaptive immunity by modulating DC matura-
tion (Akira et al., 2001), we speculated that SN cell-
induced DC maturation might be impaired in Tlr2/
mice. Thus, we examined the ability of SN cells to alter
the phenotypic and functional maturation of DCs in vitro.
The expression of surface CD80, CD86, and MHC class
II and class I on bone-marrow-derived DCs (BMDCs)
from Tlr2+/+ mice was markedly upregulated after incuba-
tion with SN cells. In contrast, the expression of CD80 and
CD86 remained virtually unaffected and that of MHC clas-
ses II and I was moderately increased on BMDCs from
Tlr2/ mice (Figure 5A). In contrast, the expression of
all tested surface markers was markedly upregulated on
BMDCs from both Tlr4+/+ and Tlr4/ mice (data not
shown). SN primary MEFs also enhanced the expression
of CD86 on splenic DCs in a TLR2-dependent manner
(Figure S5).
Next, to assess whether accumulation of dead b-cells
could provoke the priming of diabetogenic T cells subse-quent to DC activation, we used the BDC2.5 T cell recep-
tor (TCR) transgenic (tg) system (Turley et al., 2003). The
transgene-encoded TCR, derived from a diabetogenic
T cell clone of NOD mice, recognizes unidentified b-cell-
derived Ag in the context of the NOD MHC class II mole-
cule I-Ag7. When we cocultured intact apoptotic MIN6N8
cell- or SN cell-pulsed BMDCs with BDC2.5 CD4+ T cells
isolated from BDC2.5-NOD TCR tg mice (kindly provided
by C. Benoist and D. Mathis), SN cell-pulsed BMDCs in-
duced markedly enhanced proliferation of naive BDC2.5
CD4+ T cells and IFN-g secretion compared to intact apo-
ptotic cell-pulsed BMDCs in a TLR2-dependent pathway
(Figures 5B and 5C). When primary islet cells were em-
ployed instead of MIN6N8 cells, we again observed signif-
icantly decreased proliferation of BDC2.5 CD4+ T cells
and IFN-g secretion after coculture with SN islet cell-
pulsed splenic DCs from NOD.Tlr2/ mice compared to
those from NOD.Tlr2+/+ mice (Figures 5D and 5E; p <
0.05), suggesting similar TLR2-dependent stimulation of
splenic DCs by SN cells.Immunity 27, 321–333, August 2007 ª2007 Elsevier Inc. 327
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of APC In Vivo
(A) TLR2-dependent in vivo proliferation of naive BDC2.5 CD4+ T cells in the PLNs after adoptive transfer (2 3 106 cells) into 20- to 25-day-old
NOD.Tlr2+/+, NOD.Tlr2/, NOD.Tlr4+/+, or NOD.Tlr4/ recipients. Histograms show representative BDC2.5 CD4+ T cell proliferation in the PLNs,
MLNs, and the spleen of one mouse from each group assessed by CFSE dilution in CD4+Vb4+ cells, 66 hr after transfer. Graphs on the right show
the proliferation index for transferred BDC2.5 CD4+ T cells in the PLNs of each mouse (p < 0.01 between NOD.Tlr2+/+ and NOD.Tlr2/ mice;
p > 0.1 between NOD.Tlr4+/+ and NOD.Tlr4/ mice).
(B) Dispensable role for TLR2 on T cells in the priming of diabetogenic T cells. Naive BDC2.5 CD4+ T cells (23 106 cells) from BDC2.5-NOD.Tlr2+/+ or
littermate BDC2.5-NOD.Tlr2/ mice were transferred into 20- to 25-day-old NOD recipients. Histograms show representative BDC2.5 CD4+ T cell
proliferation in the PLNs of one mouse from each group assessed as in (A). The graph on the right shows the proliferation index assessed as in (A)
(p > 0.1 between BDC2.5-NOD.Tlr2+/+ and BDC2.5-NOD.Tlr2/ mice).328 Immunity 27, 321–333, August 2007 ª2007 Elsevier Inc.
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We then examined whether TLR2 regulates priming of is-
let-specific T cells by APC in vivo in NOD mice where
a wave of physiological b-cell death, peaking at 14–17
days after birth, has been reported to induce priming of di-
abetogenic T cells. After transfer of naive BDC2.5 CD4+
T cells into 20- to 25-day-old wild-type mice, prominent
BDC2.5 CD4+ T cell proliferation was detected in the
PLNs, but not in the spleens or mesenteric lymph nodes
(MLNs), as reported (Figure 6A). Of note, a significantly im-
paired priming of naive BDC2.5 CD4+ T cells was ob-
served in the PLNs of NOD.Tlr2/ (p < 0.01) but not in
those of NOD.Tlr4/ recipients (p > 0.1) (Figure 6A). In
contrast to significantly impaired priming of wild-type
BDC2.5 CD4+ T cells in TLR2-deficient recipients, TLR2
deficiency in donor BDC2.5 CD4+ T cells did not affect
their priming in the PLNs of wild-type recipient mice
(Figure 6B; p > 0.1), suggesting that TLR2 on APC but
not that on T cells is important for the priming of BDC2.5
CD4+ T cells. To support this hypothesis, we determined
whether CD11c+ DCs isolated from the PLNs of 20- to
25-day-old mice could stimulate TLR2-dependent prolif-
eration of BDC2.5 CD4+ T cells in vitro. We observed sig-
nificant proliferation of BDC2.5 CD4+ T cells after cocul-
ture with CD11c+ DCs from the PLNs but not with
CD11c+ DCs from the MLNs (Figure 6C), and this finding
is consistent with the selective in vivo priming of diabeto-
genic T cells in the PLNs. Interestingly, proliferation of
BDC2.5 CD4+ T cells was significantly less after coculture
with CD11c+ DCs from the PLNs of NOD.Tlr2/ mice
(Figure 6C; p < 0.01), suggesting that the PLNs are the
sites where DCs are activated by physiological wave of
b-cell death in a TLR2-dependent pathway in vivo and
that these DCs are able to induce the proliferation of dia-
betogenic T cells in vitro. To directly correlate TLR2-de-
pendent priming of BDC2.5 CD4+ T cells to a physiological
wave of b-cell death in vivo, we treated 20- to 25-day-old
NOD.Tlr2+/+ or NOD.Tlr2/ recipients with an irreversible
pancaspase inhibitor, zVAD, to block caspase-dependent
death in situ, and examined the priming of transferred
BDC2.5 CD4+ T cells in the PLNs. To minimize any poten-
tial effects of zVAD on donor T cells, we administered the
inhibitor 2 days before BDC2.5 CD4+ T cell transfer. Sys-
temic injection of zVAD significantly impaired the priming
of BDC2.5 CD4+ T cells (Figure 6D; p < 0.05), consistent
with the notion that caspase-dependent b-cell death is
a requisite step for diabetogenic T cell priming (Turley
et al., 2003). Importantly, this protection by zVAD was
not observed in NOD.Tlr2/ mice, suggesting a causalrelationship between a physiological wave of caspase-de-
pendent b-cell death and TLR2-dependent priming of
BDC2.5 CD4+ T cells (Figure 6D).
Next,we investigatedwhetherSTZ-induced b-cell death
leads to TLR2-dependent BDC2.5CD4+ T cell priming.We
treated recipient mice with STZ at times of minimal physi-
ological b-cell apoptosis (7 to 9 days old) and assessed the
primingof naiveBDC2.5CD4+Tcells in thePLNs.Because
it has been recognized that cytotoxic effect of STZ on pan-
creatic b-cells involves the activation of apoptotic pathway
at low doses and predominantly necrotic pathway at high
doses (Saini et al., 1996), we first determined a suitable
dose of STZ inducing caspase-dependent apoptosis of
pancreatic b-cells. Although we observed that priming of
diabetogenic T cells increased in proportion to the incre-
ment of STZ dose in NOD mice (Figure 7A), consistent
with previous observations (Zhang et al., 2002), significant
inhibition of BDC2.5 CD4+ T cell priming by zVAD was ob-
served at only 40 mg/kg STZ (p < 0.01) but not at higher
doses. Thus, we performed the following experiment with
40 mg/kg STZ: A minimal priming was seen in 7- to
9-day-old mice treated with citrate buffer alone, whereas
injection of STZ resulted in a robust priming of transferred
BDC2.5 CD4+ T cells in the PLNs of NOD.Tlr2+/+mice, but
not in those of NOD.Tlr2/ mice; these findings suggest
that TLR2 deficiency significantly impaired the priming of
BDC2.5 CD4+ T cells by STZ-induced apoptotic b-cells
(Figure 7B; p < 0.01). Again, TLR2-dependent priming
was significant at 40 mg/kg STZ but not at higher doses
(Figure 7C), suggesting an involvement of TLR2-indepen-
dent signaling in response to the increased proportion of
necrotic cells by higher doses of STZ (Figure 3G and
Figure S3). Similar results of impaired priming in the
PLNs were also observed after STZ treatment of adult
NOD.Tlr2/ mice (7 to 8 weeks old) (Figure S6A) but not
after treatment of adult NOD.Tlr4/ mice (data not
shown). We confirmed that STZ administration induced
similar degree of b-cell apoptosis between Tlr2+/+ and
Tlr2/ mice of both C57BL/6 (Figures S6B and S6C) and
NOD background (data not shown), eliminating the possi-
bility that different levels of apoptotic b-cell accumulation
contributed to the difference in T cell priming. We also
found that STZ alone or in combination with SN or PN cells
did not affect TNF-a production by macrophages and
functionalmaturation of DCs in vitro, ruling out possible ef-
fect of STZ onmacrophages or DCs (data not shown). Col-
lectively, these results suggest that apoptotic b-cell accu-
mulation, which often undergoes a secondary necrosis,
can provoke the priming of diabetogenic CD4+ T cells in(C) CD11c+ DCs were purified from the pooled PLNs or MLNs of NOD.Tlr2+/+ or NOD.Tlr2/mice (20 to 25 days old). DCs were irradiated at 3000 rad
and then incubated with naive BDC2.5 CD4+ T cells (13 105) at 0.5:1 DC to T ratio. After 3 days of culture, proliferation of BDC2.5 CD4+ T cells was
determined by measuring the incorporation of [3H]-thymidine for the next 16 hr (*p < 0.01). The data (means ± SE) represent results from two inde-
pendent experiments done in triplicate.
(D) Effect of systemic zVAD treatment on in vivo proliferation of naive BDC2.5 CD4+ T cells in the PLNs after adoptive transfer (23 106 cells) into 20- to
25-day-old NOD.Tlr2+/+ or NOD.Tlr2/ recipients. We administered zVAD 2 days before transfer of BDC2.5 CD4+ T cells. Histograms show repre-
sentative BDC2.5 CD4+ T cell proliferation in the PLNs of onemouse from each group assessed as in (A). The graph on the right shows the proliferation
index assessed as in (A) (p < 0.05 between zVAD-pretreated and untreated NOD.Tlr2+/+ mice; p > 0.1 between zVAD-pretreated and untreated
NOD.Tlr2/ mice).Immunity 27, 321–333, August 2007 ª2007 Elsevier Inc. 329
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STZ Provokes TLR2-Dependent Priming
of Naive BDC2.5 T Cells in the PLNs
(A) Recipient NOD mice (7 to 9 days old) were
treated with indicated doses of STZ for 2 con-
secutive days with or without zVAD pretreat-
ment for 2 hr. In vivo proliferation of transferred
naive BDC2.5 CD4+ T cells gated on CD4+Vb4+
cells was measured by assessment of CSFE
dilution 66 hr after adoptive transfer (2 3 106
cells). The graph shows the proliferation index
for transferred BDC2.5 CD4+ T cells in the
PLNs of each mouse (p < 0.01 between
zVAD-pretreated and untreated NOD mice at
40 mg/kg dose of STZ; p > 0.05 at 60 mg/kg;
p > 0.1 at 80 mg/kg).
(B) Recipient NOD.Tlr2+/+ or NOD.Tlr2/ mice
(7 to 9 days old) were treated with buffer or ap-
optotic dose of STZ for 2 consecutive days. In
vivo proliferation of transferred naive BDC2.5
CD4+Tcellswasassessedas in (A).Histograms
show representative BDC2.5 CD4+ T cell prolif-
eration in the PLNs of one mouse from each
group. Graph on the right shows the prolifera-
tion index assessed as in (A) (p < 0.01).
(C) Recipient NOD.Tlr2+/+ or NOD.Tlr2/ mice
(7 to 9 days old) were treated with indicated
doses of STZ for 2 consecutive days. In vivo
proliferation of naive BDC2.5 CD4+ T cells was
measured as in (A) (p < 0.01 between
NOD.Tlr2+/+ and NOD.Tlr2/ mice at 40 mg/
kg dose).the PLNs through a TLR2-dependent, but not a TLR4-de-
pendent, activation of APC.
Role for TLR2 in T Cell Function of NOD Mice
Although we observed that TLR2 on T cells is dispensable
for diabetogenic T cell priming, we further examined
whether TLR2 deficiency on T cells affects other T cell
functions of NOD mice; such functions could potentially
influence the development of diabetes. For this purpose,
we utilized a small number of NOD.Tlr2/ mice that de-
veloped diabetes. When lymphocytes from diabetic
NOD.Tlr2+/+ or diabetic NOD.Tlr2/mice with similar on-
set of diabetes and blood glucose concentration were
transferred into irradiated NOD recipients, the incidence
of diabetes was similar in both groups (Figure S7A; p >
0.1), suggesting that, once diabetes develops, TLR2 defi-
ciency on T cells does not impair diabetogenic potential of
effector T cells. To directly examine the proliferative po-
tential of TLR2-deficient T cells in vivo as a measure of
the T cell function, we transferred CD4+ T cells from
NOD.Tlr2+/+ or littermate NOD.Tlr2/mice into irradiated
NOD recipients. After adoptive transfer, homeostatic pro-
liferation of CD4+ T cells in the spleen (Figure S7B; p > 0.1)
and in peripheral LNs (data not shown) was not different
between the two groups. Consistently, proliferation of
NOD.Tlr2/ CD4+ T cells by splenic DCs from NOD
mice was not different from that of NOD.Tlr2+/+ CD4+
T cells (Figure S7C) in an in vitro DC-T cell coculture
system (Ge et al., 2002), suggesting that proliferative
potential of T cells is not affected by TLR2 on T cells.330 Immunity 27, 321–333, August 2007 ª2007 Elsevier Inc.In addition to T cell proliferation, T cell functions that
could be potentially affected by TLR2may include T helper
1 (Th1) or T helper 2 (Th2) differentiation and regulatory T
(Treg) cell function (Sutmuller et al., 2006). The develop-
ment of T1D in NOD mice could be modulated by Th1 or
Th2 environment (Jaeschke et al., 2005) or the suppressor
function of CD4+CD25+ Treg cells, particularly those ex-
pressing CD62L (Szanya et al., 2002). Therefore, we inves-
tigated whether TLR2 deficiency in T cells of NOD mice
confers an intrinsic defect on Th1-Th2 development or
the proportion and suppressor function of Treg cells.
When CD4+ T cells from NOD.Tlr2/ or NOD.Tlr2+/+
mice were cultured with anti-CD3 and anti-CD28 in the
presence of IL-12 (Th1) or IL-4 (Th2), and restimulated
with anti-CD3, IFN-g production from Th1 cells and IL-4
production from Th2 cells were not different between the
two groups (Figure S8). The percentages of CD4+CD25+
Treg cells (Figure S9A) and their expression of FoxP3 or
CD62L (Figure S9B) in the PLNs, MLNs, and the spleens
from 6- to 8-week-old NOD.Tlr2/mice were also similar
to those from littermate NOD.Tlr2+/+mice. Furthermore, in
vitro suppressor function of CD4+CD25+ Treg cells from
NOD.Tlr2/ mice was similar to that from NOD.Tlr2+/+
mice (Figure S9C), suggesting that TLR2 deficiency in
Treg cells did not affect their intrinsic suppressor function.
Next, we examined the role of TLR2 deficiency on target
b-cells in the decreased incidence of diabetes in
NOD.Tlr2/ mice. When lymphocytes from diabetic
NOD mice were transferred into irradiated NOD.Tlr2+/+
or littermate NOD.Tlr2/ mice, the incidence of diabetes
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0.1), suggesting that NOD.Tlr2+/+ and NOD.Tlr2/ mice
are equally susceptible to b-cell destruction by diabeto-
genic T cells and that TLR2 on islet b-cells is dispensable
for the development of T1D.
DISCUSSION
We show here that SN cells stimulated immune responses
more efficiently than intact apoptotic cells, and such re-
sponses lead to macrophage activation, DC maturation,
and diabetogenic T cell activation through a TLR2-depen-
dent pathway. These results suggest that TLR2 signaling
can possibly link accumulation of apoptotic cells and initi-
ation of autoimmunity in T1D. Available data indicate that
proinflammatory responses and the development of auto-
immune disorders can be elicitedwhen there is a defective
clearance of apoptotic cells (Botto et al., 1998; Hanayama
et al., 2004). Therefore, one might speculate that if apo-
ptotic cells are not engulfed by phagocytes at the proper
time, a secondary necrosis of apoptotic cells can provide
endogenous stimuli in a TLR2-dependent pathway. These
endogenous stimuli might switch the tolerogenic presen-
tation of self-peptides from apoptotic cells to the immuno-
genic one (Bratton and Henson, 2005).
Over the past few years, it has become clear that, be-
sides sensing exogenous microbial components, TLRs
also recognize endogenous material released during
cellular injury (Johnson et al., 2003a). In this way, TLRs
can be viewed as crucial surveillance receptors for detec-
tion of tissue damage, infection, and remodeling (Johnson
et al., 2003b). Indeed, recent studies have demonstrated
that TLR signaling is involved in ischemic renal and heart
diseases and allograft rejection (Leemans et al., 2005;
Goldstein et al., 2003). Although further study is required
so that the immunogenic properties of intact apoptotic
versus SN cells can be fully dissected, our data might pro-
vide a new insight into the pathogenesis of autoimmune
diabetes: Accumulation of apoptotic b-cells, which is
manifested inNODmice because of a defect in phagocytic
clearance (O’Brien et al., 2006), might be an initial trigger
for APC stimulation through TLR2, leading to the priming
of autoreactive T cells in the PLNs and autoimmune diabe-
tes in susceptible strains such as NOD mice. This mecha-
nism might explain an association of T1D with TLR2
polymorphism in patients with T1D (Park et al., 2004).
Although our study demonstrates that apoptotic cells
undergoing secondary necrosis might be an initial stimu-
lus for provoking immunity to self-Ag and promoting the
development of autoimmune diabetes in a TLR2-depen-
dent pathway, we cannot completely rule out the involve-
ment of infectious agents or other TLRs. For instance,
TLR3 is involved in dsRNA-induced islet cell death, al-
though its relevance to autoimmune diabetes remains to
be determined (Wen et al., 2004). TLR7 or TLR9 has also
been reported to be activated by endogenous nucleic
acids, released from injured cells, and to play a signi-
ficant role in the pathogenesis of rheumatoid arthritis,
systemic lupus erythematosus, or multiple sclerosis(Christensen et al., 2006; Marshak-Rothstein, 2006). Al-
though endogenous ligands released from SN cells ap-
pear to predominantly activate TLR2, other unidentified
events such as activation by exogenous ligands from in-
fectious agents or those unrelated to cell death might
also play a role as the initial events triggering autoimmune
destruction of b-cells. These TLR2-independent mecha-
nisms might explain incomplete protection of diabetes in
NODmice by TLR2 deficiency. Nonetheless, an important
role of TLR2 in the development of diabetes in NOD mice
is strongly supported by the significantly decreased inci-
dence of diabetes and attenuated severity of insulitis in
NOD.Tlr2/ mice compared to NOD.Tlr2+/+ mice. Less
incidence of diabetes in NOD.Tlr2+/+ mice compared to
NOD mice (80%90% incidence of diabetes at 45 weeks
of age in our female NOD mouse colony) might be be-
cause of the effect of unidentified B6 genes not com-
pletely replaced by NOD alleles, although we tested 15
known Idd loci for homozygosity of NOD-type alleles.
Our studies demonstrating an important role for TLR2 in
the sensing of apoptotic cells undergoing SN changes
could help investigate the therapeutic potential of target-
ing the TLR signaling pathway in tissue damage, apopto-
sis-related degenerative diseases, and other autoimmune
diseases. Regarding endogenous ligands for TLR, several
candidate molecules have been reported (Marshak-Roth-
stein, 2006). Because we do not know the exact identity of
endogenous TLR2 ligands in SN b-cells, further studieswill
be required to addresswhich TLR2 ligand(s) in SN cells are
responsible for provoking immunity by stimulating APC.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6, Balb/c, NOD/Lt, C3H/HeJ, and C3H/HeN mice were from
Jackson Laboratory. For obtaining NOD.Tlr2/ and NOD.Tlr4/
mice, Tlr2/ mice of C57BL/6 background and C3H/HeJ mice were
bred with NOD mice, and F1 (N1) progeny mice were backcrossed to
NOD mice for nine generations and intercrossed so that NOD.Tlr2/
and NOD.Tlr4/ mice [N10, backcross 9 (BC9)] could be derived, re-
spectively. Diabetes susceptibility loci Idd1 through Idd15 were geno-
typed by PCR of microsatellite markers (Mora et al., 1999). For obtain-
ing TLR2-deficient BDC2.5-NOD mice, backcrossed NOD.Tlr2/
mice were bred with BDC2.5-NOD TCR tg mice, and BDC2.5-
NOD.Tlr2+/ progeny mice were intercrossed so that BDC2.5-
NOD.Tlr2/ mice could be derived. The development of diabetes
was confirmed by nonfasting blood glucose levels above 300 mg/dl.
All mice weremaintained in a specific pathogen-free condition at Sam-
sung Biomedical Research Center Facility. All animal experiments in
this work were done in accordance with the institutional guidelines of
Samsung Medical Center.
Generation of Apoptotic and Necrotic Cells
For obtaining apoptotic cells, cells were irradiated 20 mJ/cm2 with UV
Stratalinker 2400 (Stratagene) and left for 6 hr and 30 hr intact so that
apoptotic and SN cells could be generated, respectively. Alternatively,
cell death was induced by 2.5 mM STZ, 30 mM etoposide, or a combi-
nation of 100 U/ml IFN-g and 10 ng/ml TNF-a. For determining the
mode of cell death, treated cells were analyzed by FACS with the An-
nexin V-FITC Apoptosis Detection kit (PharMingen). We achieved pri-
mary necrosis by subjecting cells to ten strokes of dounce lysis with
a Teflon homogenizer as described (Li et al., 2001) because dounce-
lysed cells induced most potent and reproducible immune responseImmunity 27, 321–333, August 2007 ª2007 Elsevier Inc. 331
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freeze-thawed cells. The supernatants were filtered through 0.22 mm
Millipore filters and used immediately. All experiments were conducted
in a sterile condition. All cells were mycoplasma free, as tested with
a PCR kit (Roche).
ELISA
Apoptotic, SN, or PN cells were added to 2 3 105 peritoneal macro-
phages (1:1 cell to macrophage ratio) with or without 100 U/ml IFN-g.
In the case of primary islet cells, apoptotic, SN, or PN cells were added
to 53 104 peritoneal macrophages (1:1 cell to macrophage ratio). After
6 hr, supernatants were harvested and tested for cytokine release with
ELISA. During the incubation time, most apoptotic cells did not un-
dergo a secondary necrosis. ELISA was conducted according to the
manufacturer’s recommendation (R&D Systems). In the case of NO
that showed delayed response (data not shown), dead cells were
washed 6 hr after incubation, and NO that accumulated for the next
12 hr was measured by the Griess method. For control experiments,
10 mg/ml of polymixin B was added to another set of samples before
incubation with macrophages. We noted no effect of polymixin B in
all cytokine responses, thereby ruling out the possibility of contamina-
tion of apoptotic, SN, or PN cells with endotoxin.
Assessment of Diabetogenic T Cell Priming
T cell primingwas assessed asdescribed (Turley et al., 2003)withmod-
ifications. Naive CD4+ T cells were prepared from the pooled spleens
by the negative-selection method with a MACS kit (Miltenyl Biotech).
Purity of CD4+ T cells was confirmed by FACS (>95%). CFSE-labeled
CD4+ T cells (2 3 106) were transferred into recipient mice by tail-
vein injection (20- to 25-day-old and 7- to 8-week-old mice) or by intra-
peritoneal injection (7- to 9-day-old mice). For zVAD treatment, zVAD
dissolved in DMSO was administered at 10 mg/kg intraperitoneally
2 days before CD4+ T cell transfer. For STZ treatment, STZ dissolved
in sodium citrate buffer immediately before injection was administered
intraperitoneally for 2 consecutive days with or without zVAD pretreat-
ment for 2 hr. Then, CFSE-labeled CD4+ T cells were transferred 24 hr
after final administration of STZ. The PLNs, MLNs, and spleens were
harvested 66 hr after transfer, and single-cell suspensionwas analyzed
for CFSE dilution by FACS gated on CD4+ and Vb4+ cells.
Statistical Analysis
The incidence of diabetes was plotted according to the Kaplan-Meier
method. The incidences between two groups were compared with the
log-rank test. For other experiments, statistical significance was deter-
mined by two-tailed Student’s t test. All p values less than 0.05 were
considered to represent statistically significant differences.
See Supplemental Experimental Procedures for cells and reagents,
Abs, EMSA, reporter assay, DC preparation, DC-T cell coculture, insu-
litis scoring, STZ-mediated induction of diabetes, identification and
quantification of apoptotic b-cells, adoptive transfer of diabetes,
Th1-Th2 differentiation, and in vitro suppression assay.
Supplemental Data
Additional Experimental Procedures and nine figures are available at
http://www.immunity.com/cgi/content/full/27/2/321/DC1/.
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